APH - AMPHENOL CORP NEW
This page shows which of the focused investors we track hold APH and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2025 it was held by 5 managers with an aggregate reported value of $965.36M, which is 0.08% of the combined portfolio.
As of Q3 2025, 5 tracked institutional managers held APH (AMPHENOL CORP NEW) with an aggregate reported value of $965.36M — 0.08% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades APH — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2025
- Ticker
- APH
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | John Armitage - Egerton Capital | 4.99% | Add +20.7% | 3,823,422 | $473.15M |
| 2 | Stephen Mandel - Lone Pine Capital | 2.72% | New | 3,023,231 | $374.12M |
| 3 | Jensen Investment Management - Jensen Investment Management | 1.34% | Reduce -66.7% | 869,464 | $107.6M |
| 4 | Torray Funds - Torray Funds | 1.37% | Reduce -15.2% | 81,701 | $10.11M |
| 5 | David Katz - Matrix Asset Advisors | 0.04% | - | 3,056 | $378.18K |
Loading holder history for APH…